Genenta Science (GNTA)

• Market cap: $56.7M
• 1 day: 0.32%
• 5 days: -11.43%
• 1 month: -13.41%
• 3 months: -5.2%
• 6 months: -20.51%
• Year to date: -31.57%
• 1 year: -6.06%
• 5 years: -71.82%
• 10 years: -71.82%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 13

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 5 [Q1] → 5 (+0) [Q2]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.01% less ownership

Funds ownership: 2.95% [Q1] → 2.94% (-0.01%) [Q2]

13% less capital invested

Capital invested by funds: $2.1M [Q1] → $1.82M (-$282K) [Q2]